Cideciyan; Artur V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cideciyan; Artur V..The latest application filed is for "aav-mediated gene therapy for nphp5 lca-ciliopathy".
- Cideciyan; Artur V. - Lafayette Hill PA
- Cideciyan; Artur V - Philadelphia PA
- CIDECIYAN; Artur V. - Philadelphia PA
| Patent | Date |
|---|---|
| Aav-mediated Gene Therapy For Nphp5 Lca-ciliopathy App 20190343920 - Aguirre; Gustavo ; et al. | 2019-11-14 |
| AAV-mediated gene therapy for RPGR X-linked retinal degeneration Grant 10,383,922 - Beltran , et al. A | 2019-08-20 |
| Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration App 20180036385 - BELTRAN; William A. ; et al. | 2018-02-08 |
| Aav-mediated Gene Therapy For Nphp5 Lca-ciliopathy App 20170348387 - Aguirre; Gustavo ; et al. | 2017-12-07 |
| AAV-mediated gene therapy for RPGR X-linked retinal degeneration Grant 9,770,491 - Beltran , et al. September 26, 2 | 2017-09-26 |
| Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration App 20150202269 - Beltran; William A ; et al. | 2015-07-23 |
| NCAGE Code | 4QH51 | CIDECIYAN ARTUR V |
| CAGE Code | 4QH51 | CIDECIYAN, ARTUR V |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 